首页 | 本学科首页   官方微博 | 高级检索  
     

人参酶解物中的皂苷成分及其对髓源抑制性细胞的作用研究
引用本文:冯孔龙,朱晓艾,刘飞,余庆涛,戴伟杰,葛亚中,陈媛媛,李赟,梁雅蕾,陈运娇,曹庸.人参酶解物中的皂苷成分及其对髓源抑制性细胞的作用研究[J].现代食品科技,2018,34(2):6-13.
作者姓名:冯孔龙  朱晓艾  刘飞  余庆涛  戴伟杰  葛亚中  陈媛媛  李赟  梁雅蕾  陈运娇  曹庸
作者单位:(1.华南农业大学食品学院,广东省天然活性物工程技术研究中心,广东广州 510642),(1.华南农业大学食品学院,广东省天然活性物工程技术研究中心,广东广州 510642),(2.广州绿萃生物科技有限公司,广东广州 510663),(3.无限极(中国)有限公司,广东广州 510665),(1.华南农业大学食品学院,广东省天然活性物工程技术研究中心,广东广州 510642),(3.无限极(中国)有限公司,广东广州 510665),(1.华南农业大学食品学院,广东省天然活性物工程技术研究中心,广东广州 510642)(3.无限极(中国)有限公司,广东广州 510665),(3.无限极(中国)有限公司,广东广州 510665),(1.华南农业大学食品学院,广东省天然活性物工程技术研究中心,广东广州 510642),(1.华南农业大学食品学院,广东省天然活性物工程技术研究中心,广东广州 510642),(1.华南农业大学食品学院,广东省天然活性物工程技术研究中心,广东广州 510642)
基金项目:广东省科技厅产学研合作项目(2016B090920093);广东省现代农业产业技术体系创新团队项目(2016LM2151)
摘    要:本文建立了同时测定人参酶解物中12种人参皂苷的高效液相色谱检测方法,探索人参提取物及酶解物主要皂苷成分差异,并以酶解前后的人参提取物作为对象,探讨其对髓源抑制性细胞(Myeloid derived suppressed cell,MDSC)的影响。人参提取物和酶解物的总皂苷含量差异不明显,而酶解物中12种人参皂苷和稀有皂苷含量(Rh1、F1、F2、Rg3、CK和Rh2)均显著高于人参提取物;稀有皂苷含量增加了4.48倍,尤其是酶解后转化生成了大量的F2和少量的F1、CK和Rh2等稀有皂苷。人参提取物及酶解物均能显著抑制MSC2细胞增殖和降低结肠癌荷瘤小鼠脾脏中的MDSC细胞比例。其中人参酶解物效果更佳,相对人参提取物,对MSC2细胞增殖抑制率提高30.00%和MDSC细胞比例降低40.50%。人参酶解物含有丰富的稀有皂苷,具有更高的生物活性,能够有效改善肿瘤微环境,从而加强了抗肿瘤能力。

关 键 词:人参提取物  人参酶解物  稀有皂苷  髓源抑制性细胞
收稿时间:2017/8/24 0:00:00

Ginsenosides of Ginseng Enzymatic Hydrolysate and Their Effects on Myeloid Derived Suppressed Cell
FENG Kong-long,ZHU Xiao-ai,LIU Fei,YU Qing-tao,DAI Wei-jie,GE Ya-zhong,CHEN Yuan-yuan,LI Yun,LIANG Ya-lei,CHEN Yun-jiao and CAO Yong.Ginsenosides of Ginseng Enzymatic Hydrolysate and Their Effects on Myeloid Derived Suppressed Cell[J].Modern Food Science & Technology,2018,34(2):6-13.
Authors:FENG Kong-long  ZHU Xiao-ai  LIU Fei  YU Qing-tao  DAI Wei-jie  GE Ya-zhong  CHEN Yuan-yuan  LI Yun  LIANG Ya-lei  CHEN Yun-jiao and CAO Yong
Affiliation:(1.College of Food Science, South China Agricultural University, Guangdong Engineering Research Center of Natural Active Substance, Guangzhou 510642, China),(1.College of Food Science, South China Agricultural University, Guangdong Engineering Research Center of Natural Active Substance, Guangzhou 510642, China),(2.Greencream Biotech Co., Ltd, Guangzhou 510663, China),(3.Infinitus (China) Co., Ltd, Guangzhou 510665, China),(1.College of Food Science, South China Agricultural University, Guangdong Engineering Research Center of Natural Active Substance, Guangzhou 510642, China),(3.Infinitus (China) Co., Ltd, Guangzhou 510665, China),(1.College of Food Science, South China Agricultural University, Guangdong Engineering Research Center of Natural Active Substance, Guangzhou 510642, China)(3.Infinitus (China) Co., Ltd, Guangzhou 510665, China),(3.Infinitus (China) Co., Ltd, Guangzhou 510665, China),(1.College of Food Science, South China Agricultural University, Guangdong Engineering Research Center of Natural Active Substance, Guangzhou 510642, China),(1.College of Food Science, South China Agricultural University, Guangdong Engineering Research Center of Natural Active Substance, Guangzhou 510642, China) and (1.College of Food Science, South China Agricultural University, Guangdong Engineering Research Center of Natural Active Substance, Guangzhou 510642, China)
Abstract:A quantitative method for simultaneous determination of 12 ginsenosides in ginseng enzymatic hydrolysate was established by using high performance liquid chromatography (HPLC). The differences of main ginsenosides between ginseng extracts and ginseng enzymatic hydrolysates were investigated., and the effects of ginseng extract on myeloid derived suppressed cell (MDSC) before and after enzymolysis was studied. The differences of total saponin content between ginseng extracts and ginseng enzymatic hydrolysates were not obvious, and the content of 12 ginsenosides and rare ginsenosides (Rh1, F1, F2, Rg3, CK and Rh2) in hydrolysates were significantly higher than those in ginseng extracts. After enzymatic hydrolysis, the content of rare ginsenosides in ginseng enzymatic hydrolysates was increased by 4.48 times, especially a large number of rare ginsenosides of F2, and a small amount of rare ginsenosides of F1, CK and Rh2 were produced. Ginseng extracts and ginseng enzymatic hydrolyzates could significantly inhibite the proliferation of MSC2 cells and reduce the proportion of MDSC cells in the spleen of colon cancer-bearing mice, and the effects of hydrolyzates were better than that of ginseng extract. Compared to ginseng extracts, the inhibition rate of ginseng enzymatic hydrolysates on MSC2 cells was increased by 30.00% and the proportion of MDSC cells was decreased by 40.50%. Consequently, the ginseng enzymatic hydrolysates were rich in rare ginsenosides and had a higher biological activity, which could effectively improve the tumor microenvironment and then enhance the anti-tumor ability.
Keywords:ginseng extract  ginseng enzymatic hydrolysate  rare ginsenosides  myeloid derived suppressed cell
本文献已被 CNKI 等数据库收录!
点击此处可从《现代食品科技》浏览原始摘要信息
点击此处可从《现代食品科技》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号